Publications by authors named "John Armato"

Claim this Profile
P
Pre-Prediabetes: Insulin Resistance Is Associated With Cardiometabolic Risk in Nonobese Patients (STOP DIABETES).
John Armato, Ralph A DeFronzo, Muhammad Abdul-Ghani, Ron Ruby

J Clin Endocrinol Metab· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are angiotensin-converting enzyme inhibitors/angiotensin receptor blockers associated with reduced severe acute respiratory syndrome coronavirus 2 infections and improved outcomes, and does race matter?
John Armato, Ralph A DeFronzo, Shih-Ting Chiu, Deanna Rider, Ronald Ruby

Diabetes Obes Metab· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment of prediabetes in clinical practice using physiological assessment (STOP DIABETES).
John P Armato, Ralph A DeFronzo, Muhammad Abdul-Ghani, Ron J Ruby

Lancet Diabetes Endocrinol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRIGLYCERIDE/HIGH-DENSITY LIPOPROTEIN CHOLESTEROL CONCENTRATION RATIO IDENTIFIES ACCENTUATED CARDIOMETABOLIC RISK.
John Armato, Gerald Reaven, Ronald Ruby

Endocr Pract· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLP-1 provoked severe hypoglycemia in an individual with type 2 diabetes and a benign insulinoma.
Ronald J Ruby, John P Armato, Charles Pyke, Anne L Peters

Diabetes Care· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful treatment of prediabetes in clinical practice: targeting insulin resistance and β-cell dysfunction.
John Armato, Ralph A DeFronzo, Muhammad Abdul-Ghani, Ron Ruby

Endocr Pract· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis